MAZE Maze Therapeutics, Inc.
$24.60
Maze Therapeutics, Inc. (MAZE) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Insider signal
In line
Selling ran in line with MAZE's own trailing one-year pace, with 88% of sale value under a prearranged plan.
Cluster activity
0 buyers in the last 30 days
0 buyers in the last 90 days
4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
5
57 transactions
Purchases
$0
0 shares
Sales
$9.7M
345,315 shares
Net activity
-$9.7M
purchases less sales
How much of that selling was preplanned? 88% planned / 12% discretionary
10b5-1 plan sales
$8.6M
41 transactions · 301,955 shares
Discretionary sales
$1.1M
16 transactions · 43,360 shares
Largest single sale: $907.9K.
Where they traded
Buy
Sell
Dot area is proportional to transaction value.
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Bernstein Harold | President, R&D & CMO | Sell 10b5-1 | 9,705 | $26.22 | $254.5K | None left | |
| Coloma Jason V 2 fills | Chief Executive Officer | Sell | 11,411 | $26.01 | $296.8K | 27,491 −29.3% of holding | |
| Bernstein Harold 2 fills | President, R&D & CMO | Sell | 5,189 | $26.01 | $135.0K | 9,764 −34.7% of holding | |
| Dandekar Atul 2 fills | CSBO | Sell | 3,243 | $26.01 | $84.4K | 32,352 −9.1% of holding | |
| Courtney Phillips 2 fills | GC and Corp. Secretary | Sell | 2,012 | $26.01 | $52.3K | 7,029 −22.3% of holding | |
| Coloma Jason V 2 fills | Chief Executive Officer | Sell | 11,227 | $26.47 | $297.1K | 40,148 −21.9% of holding | |
| Bernstein Harold 2 fills | President, R&D & CMO | Sell | 5,106 | $26.47 | $135.1K | 15,519 −24.8% of holding | |
| Dandekar Atul 2 fills | CSBO | Sell | 3,191 | $26.47 | $84.5K | 35,950 −8.2% of holding | |
| Courtney Phillips 2 fills | GC and Corp. Secretary | Sell | 1,981 | $26.47 | $52.4K | 9,262 −17.6% of holding | |
| Bernstein Harold | President, R&D & CMO | Sell 10b5-1 | 16,141 | $26.36 | $425.5K | None left | |
| Dandekar Atul | CSBO | Sell 10b5-1 | 7,500 | $27.58 | $206.8K | 26,250 −22.2% of holding | |
| Bernstein Harold | President, R&D & CMO | Sell 10b5-1 | 16,142 | $27.61 | $445.6K | None left | |
| Coloma Jason V 4 fills | Chief Executive Officer | Sell 10b5-1 | 34,501 | $26.73 | $922.3K | 256,867 −11.8% of holding | |
| Dandekar Atul 2 fills | CSBO | Sell 10b5-1 | 7,500 | $27.34 | $205.0K | 26,650 −22% of holding | |
| Coloma Jason V 3 fills | Chief Executive Officer | Sell 10b5-1 | 34,501 | $29.98 | $1.0M | 288,768 −10.7% of holding | |
| Bernstein Harold 2 fills | President, R&D & CMO | Sell 10b5-1 | 14,609 | $29.90 | $436.9K | 1,200 −92.4% of holding | |
| Dandekar Atul | CSBO | Sell 10b5-1 | 7,500 | $28.02 | $210.2K | 26,250 −22.2% of holding | |
| Coloma Jason V | Chief Executive Officer | Sell 10b5-1 | 23,865 | $26.05 | $621.7K | 319,079 −7% of holding | |
| Coloma Jason V 2 fills | Chief Executive Officer | Sell 10b5-1 | 3,993 | $26.00 | $103.8K | 342,944 −1.2% of holding | |
| Bernstein Harold 2 fills | President, R&D & CMO | Sell 10b5-1 | 14,853 | $25.66 | $381.1K | 1,600 −90.3% of holding | |
| Coloma Jason V 2 fills | Chief Executive Officer | Sell 10b5-1 | 6,643 | $26.20 | $174.0K | 344,897 −1.9% of holding | |
| Dandekar Atul | CSBO | Sell 10b5-1 | 7,500 | $26.34 | $197.6K | 24,808 −23.2% of holding | |
| Coloma Jason V | Chief Executive Officer | Sell 10b5-1 | 25,582 | $26.02 | $665.5K | 350,987 −6.8% of holding | |
| Coloma Jason V 2 fills | Chief Executive Officer | Sell 10b5-1 | 6,982 | $26.00 | $181.5K | 376,569 −1.8% of holding | |
| Coloma Jason V 2 fills | Chief Executive Officer | Sell 10b5-1 | 1,938 | $26.00 | $50.4K | 381,073 −0.5% of holding | |
| Bernstein Harold | President, R&D & CMO | Sell 10b5-1 | 15,000 | $26.22 | $393.4K | None left | |
| Dandekar Atul | CSBO | Sell 10b5-1 | 7,500 | $25.37 | $190.3K | 10,503 −41.7% of holding | |
| Bernstein Harold 3 fills | President, R&D & CMO | Sell 10b5-1 | 15,000 | $29.46 | $441.9K | 3,648 −80.4% of holding | |
| Bachrodt Amy 2 fills | SVP, Finance | Sell 10b5-1 | 2,500 | $29.44 | $73.6K | 13,265 −15.9% of holding | |
| Dandekar Atul 2 fills | CSBO | Sell 10b5-1 | 7,500 | $29.34 | $220.0K | 11,293 −39.9% of holding | |
| Bernstein Harold 3 fills | President, R&D & CMO | Sell 10b5-1 | 15,000 | $49.10 | $736.4K | 8,839 −62.9% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.